FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210632008> ?p ?o ?g. }

• W4210632008 endingPage "445" @default.
• W4210632008 startingPage "433" @default.
• W4210632008 abstract "Bovine serum albumin (BSA) has been employed as a mild biological template in nanoscale particles. Copper sulfide (CuS) has been used for photothermal therapy (PTT) in several studies. In this study, we aimed to synthesize the 131 I-labeled BSA-modified CuS nanoparticles (131 I-BSA@CuS), with attributes of both radiotherapy and PTT, as a therapeutic agent against anaplastic thyroid carcinoma (ATC). BSA@CuS nanoparticles were prepared using the solvothermal reaction and then labeled with Na131 I by the chloramine-T method. The products were characterized and their cytotoxicity was investigated in vitro and in vivo. The therapeutic efficacy of 131 I-BSA@CuS was evaluated in ARO cell (an ATC cell line) subcutaneous tumors. The nanoparticles showed good biocompatibility and low toxicity in vitro and in vivo. BSA@CuS rapidly and effectively converted the light energy from an 808 nm laser into thermal energy with a conversion efficiency of 28.07%. SPECT/CT imaging demonstrated that the accumulation of radioactivity peaked within 24 hr and resided in the tumors for 5 days post intratumoral injection. In vivo assays indicated that, compared to monotherapy, the synthesized nanoparticles employing both PTT and radiotherapy possess better therapeutic efficacy against tumors. The synthesized nanomaterial showed uniform dispersion, good stability and aqueous solubility, excellent photothermal properties, and long-term retention in ATC. Hence, combined radiotherapy and PTT can significantly inhibit tumor growth compared to monotherapy, and can be applied in clinical settings." @default.
• W4210632008 created "2022-02-08" @default.
• W4210632008 creator A5009222094 @default.
• W4210632008 creator A5026320292 @default.
• W4210632008 creator A5031810848 @default.
• W4210632008 creator A5041997201 @default.
• W4210632008 creator A5052704439 @default.
• W4210632008 creator A5067124352 @default.
• W4210632008 creator A5069548541 @default.
• W4210632008 date "2022-02-15" @default.
• W4210632008 modified "2023-10-16" @default.
• W4210632008 title "Evaluating the therapeutic efficacy of radiolabeled <scp>BSA</scp>@<scp>CuS</scp> nanoparticle‐induced radio‐photothermal therapy against anaplastic thyroid cancer" @default.
• W4210632008 cites W1951297800 @default.
• W4210632008 cites W1968128233 @default.
• W4210632008 cites W1977020389 @default.
• W4210632008 cites W1978762833 @default.
• W4210632008 cites W1984753398 @default.
• W4210632008 cites W1999456866 @default.
• W4210632008 cites W2039968749 @default.
• W4210632008 cites W2041090068 @default.
• W4210632008 cites W2065955523 @default.
• W4210632008 cites W2085526373 @default.
• W4210632008 cites W2120733004 @default.
• W4210632008 cites W2126547265 @default.
• W4210632008 cites W2138432134 @default.
• W4210632008 cites W2141753696 @default.
• W4210632008 cites W2168944768 @default.
• W4210632008 cites W2417406426 @default.
• W4210632008 cites W2534568875 @default.
• W4210632008 cites W2548265008 @default.
• W4210632008 cites W2553476573 @default.
• W4210632008 cites W2568883964 @default.
• W4210632008 cites W2605138217 @default.
• W4210632008 cites W2736254713 @default.
• W4210632008 cites W2743848379 @default.
• W4210632008 cites W2754923195 @default.
• W4210632008 cites W2786104668 @default.
• W4210632008 cites W2787460561 @default.
• W4210632008 cites W2810505935 @default.
• W4210632008 cites W2889808103 @default.
• W4210632008 cites W2915252206 @default.
• W4210632008 cites W3040736091 @default.
• W4210632008 cites W3048742421 @default.
• W4210632008 cites W4211213741 @default.
• W4210632008 doi "https://doi.org/10.1002/iub.2601" @default.
• W4210632008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35112451" @default.
• W4210632008 hasPublicationYear "2022" @default.
• W4210632008 type Work @default.
• W4210632008 citedByCount "7" @default.
• W4210632008 countsByYear W42106320082022 @default.
• W4210632008 countsByYear W42106320082023 @default.
• W4210632008 crossrefType "journal-article" @default.
• W4210632008 hasAuthorship W4210632008A5009222094 @default.
• W4210632008 hasAuthorship W4210632008A5026320292 @default.
• W4210632008 hasAuthorship W4210632008A5031810848 @default.
• W4210632008 hasAuthorship W4210632008A5041997201 @default.
• W4210632008 hasAuthorship W4210632008A5052704439 @default.
• W4210632008 hasAuthorship W4210632008A5067124352 @default.
• W4210632008 hasAuthorship W4210632008A5069548541 @default.
• W4210632008 hasConcept C121608353 @default.
• W4210632008 hasConcept C12554922 @default.
• W4210632008 hasConcept C126322002 @default.
• W4210632008 hasConcept C150903083 @default.
• W4210632008 hasConcept C171250308 @default.
• W4210632008 hasConcept C182606246 @default.
• W4210632008 hasConcept C185592680 @default.
• W4210632008 hasConcept C192562407 @default.
• W4210632008 hasConcept C202751555 @default.
• W4210632008 hasConcept C207001950 @default.
• W4210632008 hasConcept C2778997737 @default.
• W4210632008 hasConcept C2779761222 @default.
• W4210632008 hasConcept C2780256643 @default.
• W4210632008 hasConcept C502942594 @default.
• W4210632008 hasConcept C509974204 @default.
• W4210632008 hasConcept C55493867 @default.
• W4210632008 hasConcept C71924100 @default.
• W4210632008 hasConcept C86803240 @default.
• W4210632008 hasConcept C86807702 @default.
• W4210632008 hasConceptScore W4210632008C121608353 @default.
• W4210632008 hasConceptScore W4210632008C12554922 @default.
• W4210632008 hasConceptScore W4210632008C126322002 @default.
• W4210632008 hasConceptScore W4210632008C150903083 @default.
• W4210632008 hasConceptScore W4210632008C171250308 @default.
• W4210632008 hasConceptScore W4210632008C182606246 @default.
• W4210632008 hasConceptScore W4210632008C185592680 @default.
• W4210632008 hasConceptScore W4210632008C192562407 @default.
• W4210632008 hasConceptScore W4210632008C202751555 @default.
• W4210632008 hasConceptScore W4210632008C207001950 @default.
• W4210632008 hasConceptScore W4210632008C2778997737 @default.
• W4210632008 hasConceptScore W4210632008C2779761222 @default.
• W4210632008 hasConceptScore W4210632008C2780256643 @default.
• W4210632008 hasConceptScore W4210632008C502942594 @default.
• W4210632008 hasConceptScore W4210632008C509974204 @default.
• W4210632008 hasConceptScore W4210632008C55493867 @default.
• W4210632008 hasConceptScore W4210632008C71924100 @default.
• W4210632008 hasConceptScore W4210632008C86803240 @default.
• W4210632008 hasConceptScore W4210632008C86807702 @default.
• W4210632008 hasFunder F4320321001 @default.

• next